Premium
Vanadate stimulation of adenylyl cyclase: An index of tyrosine kinase vascular effects
Author(s) -
Tan Christopher M.,
Macdonald Charlotte J.,
Chorazyczewski Jozef,
Burry Andrea F.,
Feldman Ross D.
Publication year - 1999
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(99)70035-4
Subject(s) - adenylyl cyclase , adcy9 , medicine , endocrinology , tyrosine kinase , receptor tyrosine kinase , adcy10 , chemistry , biology , stimulation , receptor
Background Beyond their mitogenic effects, hormones such as insulin, which activate receptor tyrosine kinases, regulate vascular tone. Further, we have demonstrated that receptor tyrosine kinase activation enhances adenylyl cyclase activation, a prominent mechanism that mediates vasodilation. However, whether tyrosine kinase–mediated human vascular responses parallel tyrosine kinase–mediated cellular effects on adenylyl cyclase activity is unknown. Methods and Results To assess tyrosine kinase–mediated vascular responses, vascular sensitivity to insulin was assessed with the dorsal hand vein linear variable differential transformer technique. Insulin infusion resulted in a dose‐dependent relaxation in all subjects. Cellular responses were assessed by means of the insulinomimetic vanadate‐mediated sensitization of vascular adenylyl cyclase activity. Vanadate stimulated a tyrosine kinase–dependent enhancement of adenylyl cyclase function in human and rat aortic vascular smooth muscle cells, human lymphocytes, and human aortic endothelial cells. Further, maximal insulin‐mediated vasodilation was significantly positively correlated with maximal vanadate‐mediated enhancement of human lymphocyte adenylyl cyclase activity. Conclusion Insulin‐mediated vasodilation is positively correlated with vanadate‐mediated enhancement of adenylyl cyclase activity. Vanadate‐mediated enhancement of adenylyl cyclase activity in lymphocytes may represent an index of tyrosine kinase–mediated vascular effects. Clinical Pharmacology & Therapeutics (1999) 66 , 275–281; doi: